Zobrazeno 1 - 10
of 28
pro vyhledávání: '"G R, Peters"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:1944-1948
The pharmacokinetics and dose proportionality of cefmetazole were studied in 24 healthy volunteers (12 young and 12 elderly). Each volunteer received single 0.5-, 1-, and 2-g doses of cefmetazole administered intravenously over 5 min according to a t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ef0ff501dd8bccdd9b35504fbe1504a
https://doi.org/10.1128/aac.34.10.1944
https://doi.org/10.1128/aac.34.10.1944
Publikováno v:
Biopharmaceuticsdrug disposition. 19(2)
Tirilazad is a membrane lipid peroxidation inhibitor being studied for the management of subarachnoid hemorrhage; phenytoin is used for seizure prophylaxis in the same disorder. The induction of tirilazad clearance by phenytoin was assessed in 12 vol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f64c1993d8da5a9f3aeaccd6189fd121
https://pubmed.ncbi.nlm.nih.gov/9533108
https://pubmed.ncbi.nlm.nih.gov/9533108
Autor:
J C, Fleishaker, G R, Peters
Publikováno v:
International journal of clinical pharmacology and therapeutics. 35(1)
The dose proportionality of tirilazad pharmacokinetics at dosages above 6.0 mg/kg/day were assessed in 18 healthy male volunteers between the ages of 19 and 46 years. Subjects were randomized to receive either 1.5 mg/kg, 3.0 mg/kg, or 4.0 mg/kg tiril
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1334112b06780c70d9394150d706df63
https://pubmed.ncbi.nlm.nih.gov/9021439
https://pubmed.ncbi.nlm.nih.gov/9021439
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(2)
The effect of ketoconazole, a CYP3A inhibitor, on the oral bioavailability of tirilazad mesylate was assessed in 12 healthy subjects, who received the following treatments in a crossover design: a) 10 mg/kg tirilazad mesylate solution orally on the f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b6449af6cd5d76f263aee938e7949687
https://pubmed.ncbi.nlm.nih.gov/8627582
https://pubmed.ncbi.nlm.nih.gov/8627582
Publikováno v:
International journal of clinical pharmacology and therapeutics. 32(5)
Multiple dose pharmacokinetics and tolerability of tirilazad mesylate were assessed at the maximum dosage and duration expected for tirilazad mesylate therapy of subarachnoid hemorrhage and head injury. Healthy male subjects (47) received either 1 mg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98066dd5e9e7987815d455f9005e8a80
https://pubmed.ncbi.nlm.nih.gov/7921515
https://pubmed.ncbi.nlm.nih.gov/7921515
Publikováno v:
Pharmaceutical research. 11(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::319750b1e70676599b3d0851b9ab3dd9
https://pubmed.ncbi.nlm.nih.gov/8165199
https://pubmed.ncbi.nlm.nih.gov/8165199
Autor:
W J, Aseltyne, G R, Peters
Publikováno v:
Topics in health care financing. 20(3)
This chapter discusses tax exemption of integrated delivery systems, including the requirements for exemption, the charitable purposes test, the private inurement and private benefit tests, and an application to integrated delivery systems. It also d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31232d525822b30cf94648e2624aeb35
https://pubmed.ncbi.nlm.nih.gov/8191495
https://pubmed.ncbi.nlm.nih.gov/8191495
Autor:
G R, Peters
Publikováno v:
Topics in health care financing. 20(3)
This chapter discusses the nature of an integrated system, the reasons for developing an integrated delivery system, and various organizational structures that might be used. The chapter then identifies several of the critical business issues affecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b061fe21e09197209d68636cc3b22ef4
https://pubmed.ncbi.nlm.nih.gov/8191490
https://pubmed.ncbi.nlm.nih.gov/8191490
Autor:
G R, Peters
Publikováno v:
Healthcare financial management : journal of the Healthcare Financial Management Association. 45(12)
Hospitals trying for successful business cooperation with physicians have become frustrated with risky joint ventures, quick-fix recruiting plans, and management service organizations. An integrated delivery system (IDS), however, may succeed where o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb25ed9936d084fc68dd334f8bf495d9
https://pubmed.ncbi.nlm.nih.gov/10145546
https://pubmed.ncbi.nlm.nih.gov/10145546
Autor:
G R, Peters
Publikováno v:
Healthcare financial management : journal of the Healthcare Financial Management Association. 45(11)
Traditional methods for cooperation among hospitals and physicians have not been successful at warding off problems that prompt hospitals and physicians to work together in the first place. Management service organizations and income guarantees have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a0c57df5dd652afad5eb8ac08a94e616
https://pubmed.ncbi.nlm.nih.gov/10145528
https://pubmed.ncbi.nlm.nih.gov/10145528